Latest News On Clinical Trials

Latest ºÚÁϳԹÏÍø News Stories

Despite Failed Promises, Stem Cell Advocates Again Want Taxpayers To Pony Up Billions

ºÚÁϳԹÏÍø News Original

California’s stem cell agency, created by a $3 billion bond measure 15 years ago, is almost out of money. Its supporters plan to ask voters for even more funding next year, even though no agency-funded treatments have been approved for widespread use.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

ºÚÁϳԹÏÍø News Original

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

Will I Always Face The Threat Of A Peanut-Laden Kiss Of Death?

ºÚÁϳԹÏÍø News Original

A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.

Choosing Between Death And Deportation

ºÚÁϳԹÏÍø News Original

What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.

FDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research

ºÚÁϳԹÏÍø News Original

The Food and Drug Administration rarely prosecutes research violations, but its criminal division is looking into the experimental herpes vaccine research by Southern Illinois University professor William Halford.

University Under Fire For Off-The-Grid Herpes Vaccine Experiments

ºÚÁϳԹÏÍø News Original

Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.

Rep. Chris Collins’ Australian Stock Bet Looks Bleaker

ºÚÁϳԹÏÍø News Original

Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.

St. Kitts Launches Probe Of Herpes Vaccine Tests On U.S. Patients

ºÚÁϳԹÏÍø News Original

After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.

Polémica por ensayo de una vacuna contra el herpes en el extranjero

ºÚÁϳԹÏÍø News Original

El ensayo clínico de una vacuna contra el herpes común fuera de los Estados Unidos ha generado una controversia médica y una investigación gubernamental.

FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment

ºÚÁϳԹÏÍø News Original

Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.